Pacific View Asset Management’s Array Biopharma Inc ARRY Stock Holding History

Pacific View Asset Management’s Portfolio ARRY Stock Details ARRY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-14,364	Closed	-$666K	–	49
2019 Q2	$666K	Sell	14,364 -20,680	-59%	-$581K	0.72%	37
2019 Q1	$854K	Sell	35,044 -111,908	-76%	-$2.33M	0.89%	30
2018 Q4	$2.09M	Sell	146,952 -208,205	-59%	-$3.16M	2.46%	18
2018 Q3	$5.4M	Buy	355,157 +129,646	+57%	+$1.99M	4.3%	5
2018 Q2	$3.78M	Buy	+225,511	New	+$3.59M	3%	13

Other funds holding ARRY

ASN

Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return

Pacific View Asset Management's ARRY Position: Q3 2019 in Review

Pacific View Asset Management sold out of Array Biopharma Inc (ARRY) in Q3 2019, closing a stake of 14,364 shares — an estimated $666K sold.

Pacific View Asset Management first reported a position in ARRY in Q2 2018 and held it in 5 quarters. The position peaked at $5.4M in Q3 2018. 1 fund tracked by Wall St. Rank holds ARRY as of Q3 2019.

Pacific View Asset Management reported no remaining Array Biopharma Inc position as of Q3 2019 after selling out during the quarter.
Pacific View Asset Management sold 14,364 Array Biopharma Inc shares in Q3 2019, an estimated $666K.
Pacific View Asset Management first reported a position in Array Biopharma Inc in Q2 2018 and held it in 5 quarters.
Pacific View Asset Management's Array Biopharma Inc position peaked at $5.4M in Q3 2018.
1 fund tracked by Wall St. Rank held Array Biopharma Inc as of Q3 2019.

Based on Pacific View Asset Management's 13F filing for Q3 2019, filed 14 Nov 2019.